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INTRODUCTION
The first known human clinical trial
was performed in 1747 by James Lind,
when he treated 12 people suffering
from scurvy with cider, vitriol, vinegar,
seawater, garlic plus balsam of peru, or
oranges plus lemons (Bartholomew,
2002). Since that time, dramatic ad-
vances have been made in clinical tri-
als, statistical methodology, and
operational strategies, with modern
human studies often involving thou-
sands of patients across the world.
These trials have advanced scientific
and medical knowledge dramatically
from the use of citrus fruits to treat
scurvy to the planning of trials to use
genetically engineered T cells to treat
pemphigus vulgaris (Ellebrect et al.,
2016). Despite these advances, clin-
ical trials often suffer from poor
enrollment, and in some cases poor
design, which yield limited useful
knowledge for key consumers of
research findings: patients. Observa-
tional research has similar challenges,
and the absence of patient involvement
has been proposed as one of the factors
contributing to focusing on lower pri-
ority research questions, which adds to
research waste, using inappropriate
outcome measures and poor interpre-
tation, and dissemination of research
findings. As a result, key stakeholders,
including funding organizations, regu-
latory bodies, and patient organiza-
tions, are advocating for inclusion of
patients in the research process from
inception to dissemination of results
(Kirwan et al., 2017). For example, the
James Lind Alliance was established to
bring patients, care takers, and clini-
cians together to prioritize unresolved
questions about the effects of treat-
ments (Chalmers and Glasziou, 2009).
IMPORTANCE OF THE PATIENT
VOICE IN CLINICAL RESEARCH
Advances in medical care begin with
research that emphasizes outcomes
meaningful to patients (Selby et al.,
2012). Too often, clinical studies
culminate with a multitude of data, yet
analyses and recommendations fail to
fully translate into practice, leaving
unmet needs for patients. Patient
participation in all phases of the clin-
ical research enterprise from identifying
gaps in knowledge and setting research
priorities to design of protocols and
dissemination and application of the
research findings in real-world settings
is increasingly recognized as a vital
component to generating data that
promote positive changes in clinical
practice (Barry and Edgman-Levitan,
2012). The Patient Centered Outcomes
Research Institute’s, which was estab-
lished by the Patient Protection and
Affordable Care Act, engagement rubric
provides a foundation for researchers to
apply greater involvement of and
collaboration with patient partners
(Figure 1) (Sheridan et al., 2017). In the
United Kingdom, the INVOLVE initia-
tive (https://www.invo.org.uk/) supports
public involvement in all stages of
research, including providing training
and support for all stakeholders, and
the King’s fund provides practical sug-
gestions for researchers and patients
(https://www.kingsfund.org.uk/topics/
patient-involvement).
NOTED OBSTACLES AND ISSUES
While patients have inherent knowl-
edge of their experience with a disease,
they may lack basic literacy in the
myriad of issues relevant to human
research. For example, in the United
States, only 12% of adults have profi-
cient health literacy skills (Kutner et al.,
2006). This knowledge gap can lead
patients engaged in research to feel
intimidated, questioning their ability to
add value to a study. Changing the
culture of research is an ongoing pro-
cess and can be met with resistance
from professionals; encouraging in-
vestigators to take time to educate and
train stakeholders, use plain language,
and value their input enhances the
impact of patient-oriented research
(Carman and Workman, 2017). Addi-
tionally, the availability of participants
varies and may often fall outside of the
typical work hours for a research team,
requiring flexibility from both patients
and investigators. Of special impor-
tance is that patients from underrepre-
sented communities may have distrust
in the medical and scientific commu-
nity, given prior ethical breaches, and
therefore extra efforts need to be made
to establish trust and create an inclusive
environment (Corbie-Smith et al.,
1999). Finally, the cost of attracting
and retaining patient stakeholders can
fluctuate, and requires flexible budget-
ing to account for unanticipated
changes in patient engagement.
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PERSPECTIVE
ENGAGEMENT STRATEGIES AND
TOOLS
There are a variety of resources avail-
able to facilitate patient engagement
in the research process, as described
in Table 1. We encourage offering
training and providing educational
materials to participants in a manner
that allows them to access as much
information as is required, based on
their individual learning needs without
overwhelming or overburdening them
with work. Of particular importance,
incorporating visual aids and technol-
ogy improves the understanding and
recall of material for all types of
learners (Kessels, 2003). This approach
can be further enhanced through
partnering with patient advocacy or-
ganizations, which often provide
mentorship and other forms of support
for their members who participate in
research. Engaging partners through
social media, websites, and apps
draws a wider variety of participants
inclusive of more diverse experiences
and views. While in-person meetings
are not always feasible, having at least
one designated face-to-face confer-
ence boosts morale, entices further
engagement and participation, and
demonstrates to the patients their
value and the importance of their
contributions to research (see
Figure 2). Setting clear expectations
early on in the engagement process
regarding the time commitment
required and respecting patients’ time
ensures that meetings are not too
frequent where participation lags, yet
recurrent enough that patients do not
lose interest or forget the progress
already made. For example, our tele-
conference meeting schedule ranges
from weekly during key study devel-
opment periods, to monthly or quar-
terly, in order to maintain open lines
of communication and progress. This
approach can be supported with
e-mail updates, detailed agendas, and
recaps of conversations for the group
to reflect upon when not directly
engaged.
ILLUSTRATIVE EXAMPLES OF
PATIENT ENGAGEMENT
We developed a pragmatic trial of home
versus office-based phototherapy with
patient engagement from inception. First,
we conducted surveys of psoriasis pa-
tients across the United States to deter-
mine their priorities for comparative
effectiveness research,while allowing for
a broad representation of patients. We
received responses frommore than1,400
psoriasis patients who are contacts of the
National Psoriasis Foundation, which
identified a strong preference for home
phototherapy by patients as well as a
strong priority of patients for comparative
effectiveness research on this topic
(Takeshita, 2013). We then reconfirmed
these findings via Citizen Pscientist, an
online patient engagement platform
managed by the National Psoriasis
Figure 1. Engagement rubric (adapted from Patient-Centered Outcomes Research Institute). 1https://www.pcori.org/research-results/2017/pragmatic-trial-
home-versus-office-based-narrowband-ultraviolet-b-phototherapy. 2Bergstresser et al. (2012). 3https://sites.google.com/nihr.ac.uk/pi-standards/home.
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Foundation (Afifi et al., 2017). A com-
mittee of five patients (one of whom,
KP, is a co-author of this paper) informed
the study design, outcome measure-
ments, and application for funding.
We intentionally limited the committee
size as social science research generally
suggests five to seven members are
optimal for engagement. The patient
committee members are diverse in age,
duration of psoriasis, treatment experi-
ence, and skin type in order to reflect the
study target population. Some patients
were identified by the study principal
investigator and co-principal investigator
(both dermatologists) and others were
nominated by National Psoriasis Foun-
dation staff, thus ensuring inclusion of
highly motivated patients who are have
deep experience of living with psoriasis.
The application, which detailed our plan
Figure 2. Stakeholders meeting for the LITE treatment effectiveness study. An in-person meeting of patient research partners and other stakeholders was
held in September 2018 in order to achieve final input on the design of the LITE study. Patient input resulted in dropping one secondary end point in order to
reduce burden to study subjects.
Table 1. Educational resources for engaging patients in clinical research
Resource Overview Access Point
Connecting Community to
Research Toolkit
Downloadable toolkit to help deliver customized training in basic
research methods and skills for community partners engaged in
research projects.
http://sites.bu.edu/coeinwomenshealth/community/
community-services/connecting-community-to-
research/
CIRTification Interactive human subject research training videos specifically
designed in plain language for community partners and their
unique roles in research. Trainings are available in English and
Spanish.
http://www.ccts.uic.edu/content/cirtification
PCORI Methodology 101 Training
for Patients and Stakeholders
Training booklet and resource guide for all stakeholders involved
on research. Guides members in methodology, design, analysis,
and interpretation.
https://www.pcori.org/sites/default/files/PCORI-
Methodology-101-Training-Booklet-and-Resource-
Guide.pdf
Research Fundamentals Workshop
Series for Community Health
Workers/Promoters
Workshop series and activity outline focusing on basic research
concepts and fundamentals for community health workers and
stakeholders in research.
https://actri.ucsd.edu/education/Documents/
Workshop%20on%20Research%20for%
20Community%20Health%20Workers.pdf
Introduction Partners in Research
Community Scholars Training
Education for stakeholders and community partners involved in
research. Provides definitions and guidance on engagement as
well as outlines for recommended education based on
circumstances.
https://hrpo.wustl.edu/wp-content/uploads/2015/
04/2015-04-02v2-Community-Partner-Education-
Manual.pdf
INVOLVE website and resources Resource links for guidance in including the public in research.
Combines expert knowledge and experience to advance inclusion
by providing training tools, libraries, examples and community
connections.
https://www.invo.org.uk/
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for patient engagement throughout the
research process and a budget to
support our patient research
partners, was successfully approved in
September 2017 (https://www.pcori.org/
research-results/2017/pragmatic-trial-
home-versus-office-based-narrowband-
ultraviolet-b-phototherapy). The study
will involve 1,050 patients stratified in
thirds by skin type (type 1/2, type 3/4,
and type 5/6). There will be two primary
end points, one physician reported
(clear or almost clear on a global
assessment) and one patient reported
(Dermatology Life Quality Index
dichotomized to no tomild impact) with
a non-inferiority margin of 15%. Our
patient committee has telephone meet-
ings on a weekly to monthly basis in the
initial planning phases necessary to
finalize the protocol; actively partici-
pated in an in-person stakeholders
meeting in Philadelphia, PA in
September 2018 (Figure 2); contributed
to the development of the informed
consent language and the testing of data
collection tools; and selected the study
acronym, LITE (LIght Treatment Effec-
tiveness study). The patient committee
will remain engaged in the study
meeting on an approximately quarterly
basis to provide feedback and will be
involved in the interpretation and
dissemination of results. Final decisions
regarding study design, operations, and
authorship are made by an executive
committee that includes the study prin-
cipal investigator and co-principal
investigator (dermatologists), a biostat-
istician, a patient, and a National Pso-
riasis Foundation staffmember (a patient
advocacy organization). This organiza-
tional structure and our culture of
mutual respect and shared
decision making promotes active
participation by patients. Similarly, pa-
tients have been key members of the UK
Dermatology Clinical Trials Network
since its inception in 2002 and have
contributed actively to all aspects of
the network from generating research
ideas to interpreting and disseminating
trial findings (http://www.bad.org.
uk/healthcare-professionals/specialist-
groups/uk-dermatology-clinical-trials-
network).
CONCLUSIONS
The importance of the patient voice in
clinical research is increasingly recog-
nized by multiple stakeholders and in
many instances is considered manda-
tory by funding organizations. There-
fore, clinical scientists should develop
expertise in effective methods to
engage patient partners in the research
process from the point of research
prioritization through study design,
execution, and dissemination of results.
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